IPOGrid
0000926617
Company

Aspira Women's Health Inc.

In Vitro & In Vivo Diagnostic Substances · AWHL

follow-on priced OTCQX 424B3

Filing Timeline

SEC EDGAR
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
16,697,509 shares
Common Stock · Exchange OTCQX · Ticker AWHL · Selling stockholders only · Use of proceeds Proceeds from resale go to selling stockholder; no issuer proceeds · Underwriters Lincoln Park Capital Fund, LLC
2026-01-12 · 0001104659-26-002556
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2026-01-09 · 9999999995-26-000142
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
16,697,509 shares · Gross proceeds $10,000,000
Common Stock · Exchange OTCQX · Ticker AWHL · Selling stockholders only · Use of proceeds Potential proceeds from sale of Purchase Shares for working capital and general corporate purposes · Underwriters Lincoln Park Capital Fund, LLC
2025-12-31 · 0000926617-25-000018
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
2025-11-21 · 0001104659-25-115034
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-11-21 · 9999999995-25-003345
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-10-20 · 0001493152-25-018669
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2025-09-30 · 0001493152-25-016373
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
Common · Exchange OTC Markets Pink Sheets · Ticker AWHL · Selling stockholders only · Use of proceeds Proceeds from the resale will go to the Selling Stockholder, with no proceeds to the company
2025-05-07 · 0001641172-25-009032
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-05-07 · 9999999995-25-001449
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2025-05-06 · 0001641172-25-008770
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-05-01 · 0001641172-25-007948
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows RW in the pre-IPO sequence.
354,988 shares · Gross proceeds $2,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Selling stockholders only · Use of proceeds Proceeds will be received by the Selling Stockholder with no issuer proceeds · Flags self_underwritten · Underwriters self-underwritten
2025-04-16 · 0001641172-25-004935
RW withdrawn
Withdrawal request
Issuer requested withdrawal of the registration statement.
Follows S-1/A and ends the active registration process.
2025-02-13 · 0001493152-25-006236
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2025-02-11 · 0001493152-25-005769
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-01-31 · 0001493152-25-004349
FWP supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows S-1/A and supplements the active offering with updated prospectus details.
2025-01-31 · 0001493152-25-004352
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $0.75 · 16,000,000 shares
Common Stock · Exchange Nasdaq · Ticker AWH · Over-allotment 2,400,000 · Up to 16,000,000 pre-funded warrants to purchase common stock at $0.001 per share · Flags warrants · Underwriters ThinkEquity
2025-01-08 · 0001493152-25-001451
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2,566,667 shares · Gross proceeds $0.00
Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Warrants exercisable at $1.36 per share for five years · Selling stockholders only · Use of proceeds Proceeds from the sale of shares will go to the selling stockholder · Flags warrants
2024-09-05 · 0000950170-24-103965
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2024-09-03 · 9999999995-24-002710
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Use of proceeds working capital and general corporate purposes · Underwriters H.C. Wainwright & Co., LLC
2024-08-02 · 0000950170-24-090142
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2,497,054 shares · Gross proceeds $0.00
Common Stock, par value $0.001 per share · Exchange Nasdaq Capital Market · Ticker AWH · Warrants to purchase up to 1,248,527 shares of Common Stock, exercisable for cash, which could generate up to $2.8 million in gross proceeds if exercised. · Selling stockholders only · Use of proceeds No proceeds to the company from the sale; potential proceeds from warrant exercises not specified. · Flags warrants
2024-07-25 · 0000950170-24-086179
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2024-07-24 · 9999999995-24-002268
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Common Stock, $0.001 par value · Exchange Nasdaq Capital Market · Ticker AWH · Underwriters Lincoln Park Capital Fund, LLC
2024-04-26 · 0001193125-24-118507
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2024-04-25 · 9999999995-24-001132
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1 and confirms the priced prospectus.
1,571,000 shares
Common · Exchange Nasdaq · Ticker AWH · Shares issuable upon exercise of outstanding common warrants · Selling stockholders only · Use of proceeds Net proceeds from warrants exercised for cash
2024-04-11 · 0001193125-24-093240
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2024-04-11 · 9999999995-24-000937
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B5 in the pre-IPO sequence.
1,571,000 shares
Common Stock · Exchange Nasdaq · Ticker AWH · Shares issuable upon exercise of outstanding common warrants issued to selling stockholders on January 26, 2024 in a private placement · Selling stockholders only · Use of proceeds selling stockholders with no issuer proceeds
2024-04-05 · 0001193125-24-088678
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $3.50 · 1,371,000 shares · Gross proceeds $5,490,098
share of common stock issued for each share · Exchange Nasdaq Capital Market · Ticker AWH · Pre-funded warrants to purchase 200,000 shares exercisable immediately and purchase warrants exercisable on July 26, 2024 with an exercise price of $4.13 · Use of proceeds Proceeds will be used for general corporate purposes · Flags warrants · Underwriters A.G.P./Alliance Global Partners
2024-01-26 · 0001193125-24-016847
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
2023-07-24 · 0001193125-23-192330
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $10,000,000 · 715,990 shares · Gross proceeds $10,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Use of proceeds To cover expenses related to the issuance of shares, including legal and accounting fees · Underwriters Lincoln Park Capital Fund, LLC
2023-03-29 · 0001193125-23-083069
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Gross proceeds $12,500,000
Common · Exchange Nasdaq Capital Market · Ticker AWH · Use of proceeds general corporate purposes · Underwriters Cantor Fitzgerald & Co.
2023-02-10 · 0001193125-23-032882
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $0.75 · 12,000,000 shares · Gross proceeds $9,000,000
Shares of Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Each share of common stock is sold with a warrant to purchase one share of common stock · Warrants to purchase up to 12,000,000 shares of common stock with an exercise price of $0.88 per share, exercisable from August 25, 2022, to August 25, 2027 · Use of proceeds Proceeds to be used for general corporate purposes · Underwriters William Blair
2022-08-24 · 0001193125-22-228657
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Shares of Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Warrants to purchase one share of common stock with exercise price not specified, exercisable from August 2022 to August 2027 · Underwriters William Blair
2022-08-22 · 0001193125-22-226568
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $7.50 · 6,000,000 shares · Gross proceeds $45,000,000
Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Over-allotment 900,000 · Use of proceeds general corporate purposes · Underwriters William Blair, Truist Securities, Brookline Capital Markets
2021-02-05 · 0001193125-21-030907
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Common · Exchange Nasdaq Capital Market · Ticker AWH · Use of proceeds General corporate purposes · Underwriters William Blair, Truist Securities, Brookline Capital Markets
2021-02-03 · 0001193125-21-027497
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2021-01-28 · 9999999995-21-000334
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
3,150,000 shares
Common Stock · Exchange Nasdaq Capital Market · Ticker AWH · Selling stockholders only · Use of proceeds No proceeds to the company; selling stockholders reselling shares
2020-10-01 · 0000926617-20-000072
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2020-09-30 · 9999999995-20-002641
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $0.80 · 18,750,000 shares · Gross proceeds $15,000,000
common · Exchange Nasdaq · Ticker VRML · Over-allotment 2,812,500 · Use of proceeds for working capital, general corporate purposes, and additional commercial investment · Underwriters William Blair
2019-06-27 · 0001193125-19-183082
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Common Stock · Exchange Nasdaq · Ticker VRML · Use of proceeds for working capital, general corporate purposes and additional commercial investment · Underwriters William Blair
2019-06-25 · 0001193125-19-181334
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $100.00 · 50,000 shares · Gross proceeds $5,000,000
Series B Convertible Preferred Stock · Exchange Nasdaq · Ticker VRML · Use of proceeds Proceeds will be used for general corporate purposes. · Underwriters Piper Jaffray
2018-04-17 · 0000926617-18-000024
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $1.00 · 10,000,000 shares · Gross proceeds $10,000,000
Common Stock · Exchange Nasdaq · Ticker VRML · Over-allotment 1,500,000 · Underwriters Piper Jaffray
2018-04-16 · 0000926617-18-000023
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Common Stock of Vermillion, Inc. · Exchange Nasdaq · Ticker VRML · Underwriters Piper Jaffray
2018-04-12 · 0000926617-18-000015
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Series B · Exchange Nasdaq · Ticker VRML · Underwriters Piper Jaffray
2018-04-12 · 0000926617-18-000017
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2017-11-07 · 9999999995-17-002903
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
6,557,463 shares · Gross proceeds $0.00
Common · Exchange NASDAQ · Ticker VRML · Includes 2,810,338 shares issuable upon exercise of warrants exercisable after August 17, 2017 · Selling stockholders only · Use of proceeds No proceeds to the company; expenses paid by the company
2017-05-08 · 0000926617-17-000032
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B5 and marks the registration effective.
2017-05-04 · 9999999995-17-001186
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
Price $1.96 · 8,350,000 shares · Gross proceeds $16,366,000
Common Stock · Exchange NASDAQ CAPITAL MARKET · Ticker VRML · Over-allotment 1,252,500 · Use of proceeds for general corporate purposes · Underwriters Canaccord Genuity, Roth Capital Partners
2015-07-14 · 0000926617-15-000047
424B5 priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Common Stock · Exchange NASDAQ Capital Market · Ticker VRML · Underwriters Canaccord Genuity, Roth Capital Partners
2015-07-13 · 0000926617-15-000045
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
11,111,104 shares · Gross proceeds $0.00
Common Stock, $0.001 par value per share · Exchange NASDAQ · Ticker VRML · 4,166,659 shares may be issued upon exercise of warrants · Selling stockholders only · Use of proceeds no proceeds to the company
2015-05-13 · 0000926617-15-000035
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2015-05-11 · 9999999995-15-001290
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2014-10-02 · 9999999995-14-002982
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
First tracked pre-IPO filing for this issuer.
2013-08-07 · 9999999995-13-002343
Comparable Deals

10 comparable deals

Healthcare & BiotechMicro (<$50M)Last 18 months
Only 0 strict matches; expanded to 10 using nearest neighbors.
Showing top 8 by similarity.
+3.9%
Median day-1
50%
Above issue
-1.3%
Median week-1
-35.3%
Downside (p10)
Functional Brands Inc. MEHA
2025-11-05 $6M Day 1: -35.3% Wk 1: -85.4%
same SIC groupnearby deal sizerecent IPO
Radiopharm Theranostics Ltd RADX
2024-12-05 $19M Day 1: +215.5% Wk 1: +2.3%
same SIC groupnearby deal sizerecent IPO
Aardvark Therapeutics, Inc. AARD
2026-02-06 $94M Day 1: -20.9% Wk 1: -23.3%
same SIC grouprecent IPO
Agomab Therapeutics NV AGMB
2026-02-06 $200M Day 1: -8.4% Wk 1: -2.1%
same SIC grouprecent IPO
Eikon Therapeutics, Inc. EIKN
2026-02-05 $381M Day 1: -16.7% Wk 1: -19.5%
same SIC grouprecent IPO
Veradermics, Inc MANE
2026-02-04 - Day 1: +11.0% Wk 1: +19.0%
same SIC grouprecent IPO
Caring Brands, Inc. CABR
2025-11-12 - Day 1: +0.0% Wk 1: -74.5%
same SIC grouprecent IPO
Evommune, Inc. EVMN
2025-11-06 $150M Day 1: +26.4% Wk 1: +22.0%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.